Isogenic cell models revealed that RAS pathway mutations reconfigure chromatin accessibility and modulate WNT signaling, with elevated TCF7L2 expression in BRAF-mutant tumors independently predicting worse overall survival. (Cell Commun Signal)
KRAS and BRAF mutations drive distinct chromatin and transcriptional programs
The CRC Digest